What Researchers Did
Researchers reported a case of a male in his early 40s with cilioretinal artery occlusion secondary to central retinal vein occlusion, who was treated with hyperbaric oxygen therapy and an intravitreal anti-vascular endothelial growth factor injection.
What They Found
The patient achieved full and sustained anatomical and functional recovery, with visual acuity improving from 8/10 to 10/10. This suggests a potential synergistic benefit of combining anti-vascular endothelial growth factor therapy with hyperbaric oxygen therapy for mixed retinal vascular occlusion.
Canadian Relevance
This study has no direct Canadian connection as it is a single case report from an unspecified location outside of Canada.
Study Limitations
A significant limitation of this study is that it is a single case report, meaning its findings cannot be generalized to a broader patient population.